FierceBiotech  Jan 23  Comment 
Enteris BioPharma signs oral diabetes pact with Sanofi badams Mon, 01/23/2017 - 08:24
Yahoo  Jan 20  Comment 
PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he...
The Hindu Business Line  Jan 19  Comment 
Sanofi-Synthelabo’s acquisition of consumer health care business of Boehringer Ingelheim among the plans cleared
FierceBiotech  Jan 19  Comment 
Rebooted Merrimack names Sanofi Genzyme SVP as CEO nick.paul.taylor Thu, 01/19/2017 - 02:27
newratings.com  Jan 18  Comment 
PARIS (dpa-AFX) - Sanofi announced that the European Commission has granted marketing authorization in Europe for Suliqua, the once-daily titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist...
Motley Fool  Jan 15  Comment 
Issues with programs developed in collaboration with Sanofi kept the otherwise promising biotech stock depressed.
FiercePharma  Jan 11  Comment 
JPM need-to-know, Chapter 2: Pfizer's deal hunger; Sanofi's dupilumab rollout and more tracy Wed, 01/11/2017 - 07:56
Benzinga  Jan 10  Comment 
After the close on Monday, Amgen, Inc. (NASDAQ: AMGN) announced that the U.S. District Court of Delaware had denied the motion by Sanofi SA (ADR) (NYSE: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to stay the injunction pending the...
newratings.com  Jan 10  Comment 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) issued a statement regarding the U.S. District Court of Delaware's denial of Sanofi and Regeneron's motion to stay the injunction pending the appeal in the ongoing PCSK9 patent litigation. The U.S....

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki